DNTH financials
Dianthus Therapeutics (DNTH) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
DNTH income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $2.04M | $2.04M | -$177.93M | -$162.34M | -4.20 |
| 2024 | $6.24M | $6.24M | -$101.86M | -$84.97M | -2.55 |
| 2023 | $2.83M | $2.83M | -$48.17M | -$43.55M | -8.45 |
| 2022 | $6.42M | $6.42M | -$29.70M | -$28.48M | -7.60 |
| 2021 | $1.48M | $1.48M | -$13.09M | -$13.11M | -3.82 |
| 2020 | $0.00 | -$1.98M | -$78.70M | -$74.94M | -27.30 |
- DNTH revenue was $2.04M in fiscal 2025, net income -$162.34M.
Updated 2026-11-07 11:53 UTC